In the case of HCC, JQ1 suppresses HCC tumorigenesis by reducing the expression of active-enhancer-related genes such as the oncogene c-MYC and the cell cycle regulatory molecule E2F2 [9–11]. The gene discussed is E2F2; the disease is hepatocellular carcinoma.